Jones Elaine V 4

What Happened
Elaine V. Jones, a director of NextCure, Inc. (NXTC), was granted a derivative award on June 18, 2026 covering 2,340 shares. The reported price per share is $0.00 (no cash exchanged) and the filing classifies the transaction as an award/grant (derivative). The award appears to be an option that will vest in full on the earlier of June 18, 2027 or the date of the 2027 Annual Meeting of Stockholders.

Key Details

• Transaction date: 2026-06-18; Form 4 filed: 2026-06-22 (filing appears timely).
• Award: 2,340 shares (derivative); reported price $0.00; total reported cash value $0.
• Vesting: Vests in full on earlier of June 18, 2027 and the 2027 Annual Meeting (per footnote).
• Shares owned after transaction: Not specified in the reported filing.
• Filing code: A (grant/award). No 10b5-1, tax-withholding, or cashless-sale notes were included in the provided data.

Context
This was a compensation award (a derivative option grant), not an open-market purchase or sale. Such grants are common for board members and represent potential future ownership if vesting and any exercise conditions are satisfied; they do not indicate an immediate cash outlay or sale.